Group 1 - The company Longhua Chemical Technology Co., Ltd. has convened a board meeting to discuss the issuance of shares through a simplified procedure to specific targets, which has been authorized by the 2024 annual shareholders' meeting [1][2] - The board has confirmed that the company meets the qualifications and conditions for issuing shares under the simplified procedure as per relevant laws and regulations [1][2] - The issuance will require approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission before implementation [2] Group 2 - The type of shares to be issued is domestic listed ordinary shares (A shares) with a par value of RMB 1.00 per share [2][3] - The issuance will be completed within ten working days after the registration decision by the China Securities Regulatory Commission [2][3] Group 3 - The issuance targets will not exceed 35 entities, including qualified institutional investors and other legal entities or individuals [3][4] - All issuance targets will subscribe at the same price and pay in cash [3][4] Group 4 - The pricing benchmark date for the issuance will be the first day of the issuance period, with the issuance price set at no less than 80% of the average stock price over the 20 trading days prior to the benchmark date [4][5] - Adjustments to the issuance price will be made if there are any dividend distributions or capital increases during the pricing period [4][5] Group 5 - The number of shares to be issued will be determined based on the total amount of funds raised divided by the issuance price, not exceeding 30% of the total share capital before the issuance [5][6] - The total amount to be raised is capped at RMB 230 million, with net proceeds allocated to specific projects [6][7] Group 6 - The shares issued will be subject to a six-month lock-up period from the date of issuance [6][7] - The profits retained before the issuance will be shared among both new and existing shareholders after the completion of the issuance [7][8] Group 7 - The validity period for the resolution regarding the issuance is from the date of approval by the 2024 annual shareholders' meeting until new regulations are issued [7][8] - The board has authorized the management to adjust the issuance plan according to new regulations if necessary [8][9] Group 8 - The company has appointed an auditing firm to provide specialized audit services for the issuance [12][13] - A second extraordinary shareholders' meeting is scheduled for August 18, 2025, to review matters requiring shareholder approval [13]
长华化学: 第三届董事会第十七次会议决议公告